Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.
2.

β-Glucuronidase is a suitable internal control gene for mRNA quantitation in pathophysiological and non-pathological livers.

Yamaguchi H, Matsumoto S, Ishibashi M, Hasegawa K, Sugitani M, Takayama T, Esumi M.

Exp Mol Pathol. 2013 Oct;95(2):131-5. doi: 10.1016/j.yexmp.2013.06.005. Epub 2013 Jun 14.

PMID:
23769876
3.

Relationship between serum b2-microglobulin levels and virological breakthrough in HBeAg-negative chronic hepatitis B patients, under long-term treatment schedules including lamivudine.

Elefsiniotis IS, Moulakakis A, Pantazis KD, Glynou I, Ketikoglou I, Vezali E, Kada H, Tsianos E.

World J Gastroenterol. 2005 Apr 7;11(13):1922-8.

4.

Serum beta2-microglobulin levels in hepatitis B e antigen-negative chronic hepatitis B patients under long term lamivudine monotherapy: relationship with virological breakthrough.

Elefsiniotis IS, Scarmeas N, Glynou I, Pantazis KD, Kada H, Mavrogiannis C.

Can J Gastroenterol. 2004 May;18(5):307-13.

PMID:
15152280
5.

Pilot study of natural human interleukin-2 in patients with chronic hepatitis B. Immunomodulatory and antiviral effects.

Tilg H, Vogel W, Tratkiewicz J, Aulitzky WE, Herold M, Gruber M, Geissler D, Umlauft F, Judmaier G, Schwulera U, et al.

J Hepatol. 1993 Sep;19(2):259-67.

PMID:
8301059
6.

Changes of serum neopterin, beta 2-microglobulin and interferon-gamma in patients with chronic hepatitis C treated with interferon-alpha 2b.

Fuchs D, Norkrans G, Wejstal R, Reibnegger G, Weiss G, Weiland O, Schvarcz R, Fryden A, Wachter H.

Eur J Med. 1992 Jul-Aug;1(4):196-200.

PMID:
1341444

Supplemental Content

Loading ...
Support Center